1. Home
  2. EHC vs BIO Comparison

EHC vs BIO Comparison

Compare EHC & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EHC
  • BIO
  • Stock Information
  • Founded
  • EHC 1983
  • BIO 1952
  • Country
  • EHC United States
  • BIO United States
  • Employees
  • EHC N/A
  • BIO N/A
  • Industry
  • EHC Hospital/Nursing Management
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • EHC Health Care
  • BIO Industrials
  • Exchange
  • EHC Nasdaq
  • BIO Nasdaq
  • Market Cap
  • EHC 9.3B
  • BIO 9.1B
  • IPO Year
  • EHC 1986
  • BIO N/A
  • Fundamental
  • Price
  • EHC $94.70
  • BIO $342.73
  • Analyst Decision
  • EHC Strong Buy
  • BIO Strong Buy
  • Analyst Count
  • EHC 8
  • BIO 4
  • Target Price
  • EHC $106.75
  • BIO $414.00
  • AVG Volume (30 Days)
  • EHC 562.9K
  • BIO 159.4K
  • Earning Date
  • EHC 02-06-2025
  • BIO 02-13-2025
  • Dividend Yield
  • EHC 0.72%
  • BIO N/A
  • EPS Growth
  • EHC 18.07
  • BIO N/A
  • EPS
  • EHC 4.14
  • BIO N/A
  • Revenue
  • EHC $5,215,000,000.00
  • BIO $2,580,209,000.00
  • Revenue This Year
  • EHC $12.53
  • BIO N/A
  • Revenue Next Year
  • EHC $9.12
  • BIO $2.92
  • P/E Ratio
  • EHC $22.29
  • BIO N/A
  • Revenue Growth
  • EHC 11.15
  • BIO N/A
  • 52 Week Low
  • EHC $69.95
  • BIO $262.12
  • 52 Week High
  • EHC $104.55
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • EHC 50.21
  • BIO 53.95
  • Support Level
  • EHC $90.67
  • BIO $334.57
  • Resistance Level
  • EHC $92.95
  • BIO $355.05
  • Average True Range (ATR)
  • EHC 1.78
  • BIO 10.12
  • MACD
  • EHC 0.50
  • BIO 1.22
  • Stochastic Oscillator
  • EHC 89.54
  • BIO 61.48

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: